Texas Capital Bancshares Inc/Tx (TCBIO) Capital Expenditures (2011 - 2026)

Texas Capital Bancshares (TCBIO) has reported Capital Expenditures for 16 consecutive years, with $10.0 million the latest figure, recorded in Q2 2026.

• Quarterly Capital Expenditures rose 80.3% year-over-year to $10.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $16.0 million (down 47.76% YoY) and the FY2025 annual result came in at $12.6 million, down 80.62% from the prior year.
• Capital Expenditures improved to $10.0 million in Q2 2026 per TCBIO's latest filing, from $1.4 million in the prior quarter.
• Over the last five years, Capital Expenditures for TCBIO reached as high as $22.2 million in Q2 2024 and fell as low as -$341000.0 in Q4 2025.
• A 5-year average of $6.5 million and a median of $4.3 million in 2023 frame the typical range for Capital Expenditures.
• Annual changes were most pronounced in 2024 — Capital Expenditures soared 1370.51% — and 2025, when it plunged 104.6%.
• Year by year, Capital Expenditures stood at $814000.0 in 2022, then soared by 358.48% to $3.7 million in 2023, then jumped by 98.45% to $7.4 million in 2024, then tumbled by 104.6% to -$341000.0 in 2025, then surged by 3031.38% to $10.0 million in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $10.0 million, $1.4 million, and -$341000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.